6,632
Views
9
CrossRef citations to date
0
Altmetric
Review Articles

The toxicology of chrysotile-containing brake debris: implications for mesothelioma

&
Pages 11-35 | Received 24 May 2018, Accepted 08 Jan 2019, Published online: 15 Mar 2019

References

  • [ACGIH] ACoGIH. 2005. TLVs and BEIs: based on the documentation of the threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati (OH): ACGIH.
  • [CEN] ECfS. 1993. Workplace atmospheres-size fraction definitions for measurement of airborne particles. London, England: CEN, British Standards Institute.
  • Agudo A, González CA, Bleda MJ, Ramírez J, Hernández S, López F, Calleja A, Panadès R, Turuguet D, Escolar A, et al. 2000. Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain. Am J Ind Med. 37:159–168.
  • AIA. 1984. Method for the determination of airborne asbestos fibres and other inorganic fibres by scanning electron microscopy. Health and Safety Publ RTM No. 2. London: AIA.
  • Ameille J, Rosenberg N, Matrat M, Descatha A, Mompoint D, Hamzi L, Atassi C, Vasile M, Garnier R, Pairon JC. 2012. Asbestos-related diseases in automobile mechanics. Ann Occup Hyg. 56:55–60.
  • Asgharian B, Hofmann W, Miller FJ. 2001. Mucociliary clearance of insoluble particles from the tracheobronchial airways of the human lung. J Aerosol Sci. 32:817–832.
  • Atkinson MA, O'Sullivan M, Zuber S, Dodson RF. 2004. Evaluation of the size and type of free particulates collected from unused asbestos-containing brake components as related to potential for respirability. Am J Ind Med. 46:545–553.
  • Aust AE, Cook PM, Dodson RF. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J Toxicol Environ Health B Crit Rev. 14:40–75.
  • Baron P. 2017. Chapter FI, measurement of fibers. In: Ashley K, O’Connor PF, editors. NIOSH manual of analytical methods (NMAM). 5th ed. Washington (DC): Centers for Disease Control and Prevention.
  • Belhocine A, Bouchetara M. 2012. Thermal analysis of a solid brake disc. Appl Therm Eng. 32:59–67.
  • Bellmann B, Konig H, Muhle H, Pott F. 1986. Chemical durability of asbestos and of man-made mineral fibers in vivo. J Aerosol Sci. 17:341–345.
  • Benedetti S, Nuvoli B, Catalani S, Galati R. 2015. Reactive oxygen species a double-edged sword for mesothelioma. Oncotarget. 6:16848–16865.
  • Berman DW, Crump KS. 2008a. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 38:49–73.
  • Berman DW, Crump KS. 2008b. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 38:1–47.
  • Bernstein D, Rogers R, Smith P. 2005. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol. 17:1–14.
  • Bernstein DM, Chevalier J, Smith P. 2005. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol. 17:427–449.
  • Bernstein DM, Morscheidt C, Grimm H-G, Thévenaz P, Teichert U. 1996. Evaluation of soluble fibers using the inhalation biopersistence model, a nine-fiber comparison. Inhal Toxicol. 8:345–385.
  • Bernstein DM, & Riego-Sintes JM. 1999. Methods for the Determination of the Hazardous Properties for Human Health of Man Made Mineral Fibres (MMMF) (Report No. EUR 18748), Brussels, European Commission Joint Research Centre, European Chemicals Bureau.
  • Bernstein DM, Rogers R, Smith P. 2004. The biopersistence of Brazilian chrysotile asbestos following inhalation. Inhal Toxicol. 16:745–761.
  • Bernstein DM, Rogers RA, Sepulveda R, Kunzendorf P, Bellmann B, Ernst H, Creutzenberg O, Phillips JI. 2015. Evaluation of the fate and pathological response in the lung and pleura of brake dust alone and in combination with added chrysotile compared to crocidolite asbestos following short-term inhalation exposure. Toxicol Appl Pharmacol. 283:20–34.
  • Berry G, Newhouse ML. 1983. Mortality of workers manufacturing friction materials using asbestos. Br J Ind Med. 40:1–7.
  • Blake CL, Van Orden DR, Banasik M, Harbison RD. 2003. Airborne asbestos concentration from brake changing does not exceed permissible exposure limit. Regul Toxicol Pharmacol: RTP. 38:58–70.
  • Boillat MA, Lob M. 1973. Risk of asbestosis in workers employed in replacing automobile brake linings. Schweiz Med Wochenschr. 103:1354–1359.
  • Brown J, Gordon T, Price O, Asgharian B. 2013. Thoracic and respirable particle definitions for human health risk assessment. Part Fibre Toxicol. 10:12.
  • Bruch J, Rehn S, Rehn B, Borm PJ, Fubini B. 2004. Variation of biological responses to different respirable quartz flours determined by a vector model. Int J Hyg Environ Health. 207:203–216.
  • Cattaneo A, Gualtieri AF, Artioli G. 2003. Kinetic study of the dehydroxylation of chrysotile asbestos with temperature by in situ XRPD. Phys Chem Miner. 30:177–183.
  • Cely-Garcia MF, Sanchez M, Breysse PN, Ramos-Bonilla JP. 2012. Personal exposures to asbestos fibers during brake maintenance of passenger vehicles. Ann Occup Hyg. 56:985–999.
  • Cely-Garcia MF, Torres-Duque CA, Duran M, Parada P, Sarmiento OL, Breysse PN, Ramos-Bonilla JP. 2015. Personal exposure to asbestos and respiratory health of heavy vehicle brake mechanics. J Expos Sci Environ Epidemiol. 25:26–36.
  • Chernova T, Murphy FA, Galavotti S, Sun XM, Powley IR, Grosso S, Schinwald A, Zacarias-Cabeza J, Dudek KM, Dinsdale D, et al. 2017. Long-fiber carbon nanotubes replicate asbestos-induced mesothelioma with disruption of the tumor suppressor gene Cdkn2a (Ink4a/Arf). Curr Biol. 27:3302–3314.e6.
  • Cherrie JW, Brosseau LM, Hay A, Donaldson K. 2013. Low-toxicity dusts: current exposure guidelines are not sufficiently protective. Ann Occup Hyg. 57:685–691.
  • Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, Macnee W, Poland CA, Tran CL, Donaldson K. 2012. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal-oxide nanoparticles. Toxicol Sci. 126:469–477.
  • Churg A, Stevens B. 1995. Enhanced retention of asbestos fibers in the airways of human smokers. Am J Respir Crit Care Med. 151:1409–1413.
  • Churg A, Wright JL. 1994. Persistence of natural mineral fibers in human lungs: an overview. Environ Health Perspect. 102:229–233.
  • Churg A. 2003. Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic Biol Med. 34:1230–1235.
  • Clin B, Paris C, Ameille J, Brochard P, Conso F, Gislard A, Laurent F, Letourneux M, Luc A, Schorle E, et al. 2011. Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? Thorax. 66:985–991.
  • Clouter A, Brown D, Hohr D, Borm P, Donaldson K. 2001. Inflammatory effects of respirable quartz collected in workplaces versus standard DQ12 quartz: particle surface correlates. Toxicol Sci. 63:90–98.
  • Coggon D, Inskip H, Winter P, Pannett B. 1995. Differences in occupational mortality from pleural cancer, peritoneal cancer, and asbestosis. Occup Environ Med. 52:775–777.
  • Coin PG, Roggli VL, Brody AR. 1992. Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ Res. 58:97–116.
  • Coin PG, Roggli VL, Brody AR. 1994. Persistence of long, thin chrysotile asbestos fibers in the lungs of rats. Environ Health Perspect. 102:197–199.
  • HSE. 2018. Asbestos-related diseases in Great Britain, 2018. HSE Books, Sadbury, Suffolk.
  • Davis J, Addison J, Bolton R, Donaldson K, Jones A, Smith T. 1986. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol. 67:415–430.
  • Davis JM, Bolton RE, Douglas AN, Jones AD, Smith T. 1988. Effects of electrostatic charge on the pathogenicity of chrysotile asbestos. Br J Ind Med. 45:292–299.
  • Davis JM, Jones AD. 1988. Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol. 69:717–737.
  • Davis JMG, Coniam SW. 1973. Experimental studies on the effects of heated chrysotile asbestos and automobile brake lining dust injected into the body cavities of mice. Exp Mol Pathol. 19:339–353.
  • Deane L. 1899. Report on the health of workers in asbestos and other dusty trades. London: HMSO.
  • Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. 2006. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci. 92:5–22.
  • Donaldson K, Borm PJ. 1998. The quartz hazard: a variable entity. Ann Occup Hyg. 42:287–294.
  • Donaldson K, Murphy F, Duffin R, Poland C. 2010. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 7:5.
  • Donaldson K, Schinwald A, Murphy F, Cho WS, Duffin R, Tran L, Poland C. 2012. The biologically effective dose in inhalation nanotoxicology. Acc Chem Res.
  • Donaldson K, Tran CL. 2004. An introduction to the short-term toxicology of respirable industrial fibres. Mutat Res. 553(1–2):5–9.
  • Duffin R, Clouter A, Brown DM, Tran CL, MacNee W, Stone V, Donaldson K. 2002. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg. 46:242–245.
  • Duffin R, Gilmour PS, Schins RP, Clouter A, Guy K, Brown DM, MacNee W, Borm PJ, Donaldson K, Stone V. 2001. Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-kappaB activation. Toxicol Appl Pharmacol. 176:10–17.
  • EC. 2008. Regulation 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directive 67/548/EEC and 1999/45/EC and amending Regulation (EC) No 1907/2006. Off J Eur Union. 51:1–1357.
  • Egilman DS, Billings MA. 2005. Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability. Int J Occup Environ Health. 11:360–371.
  • Eikermann M, Houle TT. 2016. Antagonism of neuromuscular block: all things are poison; only the dose makes a thing not a poison. Br J Anaesth. 116:157–159.
  • EPA. 2018. U.S. federal bans on asbestos. Washington D.C. USA: EPA; [accessed 2018 Apr 3]. https://www.epa.gov/asbestos/us-federal-bans-asbestos.
  • Erdinc M, Erdinc E, Cok G, Polatli M. 2003. Respiratory impairment due to asbestos exposure in brake-lining workers. Environ Res. 91:151–156.
  • Ferrer J, Garcia-Valero J, Montes JF. 2008. Chapter 10, pleural reaction to mineral dusts. In: Light RW, Lee YCG, editors. Textbook of pleural diseases. 2nd ed. Boca Raton, FL: CRC Press; p. 11.
  • Ferrer J, Orriols R, Tura JM, Lirola J, Xaus C, Vidal X. 1994. Energy-dispersive X-ray analysis and scanning electron microscopy of pleura. Study of reference, exposed non-pneumoconiotic, and silicotic populations. Am J Respir Crit Care Med. 149(Pt 1):888–892.
  • Finkelstein MM. 2013. Letter concerning the paper by Finley and colleagues: dx.doi.org/10.1016/j.yrtph.2012.05.015. Regul Toxicol Pharmacol. 65:178–179.
  • Finkelstein MM. 2015. Asbestos fibres in the lungs of an American mechanic who drilled, riveted, and ground brake linings: a case report and discussion. Ann Occup Hyg. 59:525–527.
  • Finley BL, Pierce JS, Paustenbach DJ, Galbraith DA. 2013. Response to a letter to the Editor by Dr. Murray M. Finkelstein regarding the article by Finley et al. (2012). Regul Toxicol Pharmacol. 65:180–181.
  • Finley BL, Pierce JS, Paustenbach DJ, Scott LL, Lievense L, Scott PK, Galbraith DA. 2012. Malignant pleural mesothelioma in US automotive mechanics: reported vs expected number of cases from 1975 to 2007. Regul Toxicol Pharmacol: RTP. 64:104–116.
  • Finley BL, Richter RO, Mowat FS, Mlynarek S, Paustenbach DJ, Warmerdam JM, Sheehan PJ. 2007. Cumulative asbestos exposure for US automobile mechanics involved in brake repair (circa 1950s–2000). J Expo Sci Environ Epidemiol. 17:644–655.
  • Fisher GL, Mossman BT, McFarland AR, Hart RW. 1987. A possible mechanism of chrysotile asbestos toxicity. Drug Chem Toxicol. 10:109–131.
  • Fubini B, Barcelo F, Arean CO. 1997. Ferritin adsorption on amosite fibers: possible implications in the formation and toxicity of asbestos bodies. J Toxicol Environ Health. 52:343–352.
  • Fubini B, Mollo L. 1995. Role of iron in the reactivity of mineral fibers. Toxicol Lett. 82–83:951–960.
  • Fubini B. 1997. Surface reactivity in the pathogenic response to particulates. Environ Health Perspect. 105:1013–1020.
  • Ganguly A, George R. 2008. Asbestos free friction composition for brake linings. Bull Mater Sci. 31:19–22.
  • Garabrant DH, Alexander DD, Miller PE, Fryzek JP, Boffetta P, Teta MJ, Hessel PA, Craven VA, Kelsh MA, Goodman M. 2016a. Mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. Ann Occup Hyg. 60:8–26.
  • Garabrant DH, Alexander DD, Miller PE, Fryzek JP, Boffetta P, Teta MJ, Hessel PA, Craven VA, Kelsh MA, Goodman M. 2016b. Response to Kay Teschke. Re: mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. Ann Hyg. 60:1036–1037.
  • Gazzano E, Turci F, Foresti E, Putzu MG, Aldieri E, Silvagno F, Lesci IG, Tomatis M, Riganti C, Romano C, et al. 2007. Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. Chem Res Toxicol. 20:380–387.
  • Ghio AJ, Churg A, Roggli VL. 2004. Ferruginous bodies: implications in the mechanism of fiber and particle toxicity. Toxicol Pathol. 32:643–649.
  • Ghio AJ, LeFurgey A, Roggli VL. 1997. In vivo accumulation of iron on crocidolite is associated with decrements in oxidant generation by the fiber. J Toxicol Environ Health. 50:125–142.
  • Giantomassi F, Gualtieri AF, Santarelli L, Tomasetti M, Lusvardi G, Lucarini G, Governa M, Pugnaloni A. 2010. Biological effects and comparative cytotoxicity of thermal transformed asbestos-containing materials in a human alveolar epithelial cell line. Toxicol In Vitro. 24:1521–1531.
  • Gilham C, Rake C, Burdett G, Nicholson AG, Davison L, Franchini A, Carpenter J, Hodgson J, Darnton A, Peto J. 2016. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup Environ Med. 73:290–299.
  • Goodman M, Teta MJ, Hessel PA, Garabrant DH, Craven VA, Scrafford CG, Kelsh MA. 2004. Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Ann Occup Hyg. 48:309–326.
  • Greim H, Utell MJ, Maxim LD, Niebo R. 2014. Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers. Inhal Toxicol. 26:789–810.
  • Grigoratos T, Martini G. 2015. Brake wear particle emissions: a review. Environ Sci Pollut Res. 22:2491–2504.
  • Gualtieri AF, Pollastri S, Bursi Gandolfi N, Gualtieri ML. 2018. In vitro acellular dissolution of mineral fibres: a comparative study. Sci Rep. 8:7071.
  • Gualtieri AF, Tartaglia A. 2000. Thermal decomposition of asbestos and recycling in traditional ceramics. J Eur Ceram Soc. 20:1409–1418.
  • Gualtieri AF, Viani A, Sgarbi G, Lusvardi G. 2012. In vitro biodurability of the product of thermal transformation of cement-asbestos. J Hazard Mater. 205–206:63–71.
  • Gustavsson P, Plato N, Lidstrom EB, Hogstedt C. 1990. Lung cancer and exposure to diesel exhaust among bus garage workers. Scand J Work Environ Health. 16:348–354.
  • Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. 2009. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol. 6:35.
  • Hansen ES. 1989. Mortality of auto mechanics. A ten-year follow-up. Scand J Work Environ Health. 15:43–46.
  • Hansen J, Meersohn A. 2003. Kraeftsygelighed blandt danske lonmodtagere (1970–97) fordelt pa Arbejdstilsynets 49 branchegrupper. Kobenhavn: Institut for Epidemiologisk Kraeftforskning, Kraeftens Bekaempelse.
  • Hardy JA, Aust AE. 1995a. Iron in asbestos chemistry and carcinogenicity. Chem Rev. 95:97–118.
  • Hardy JA, Aust AE. 1995b. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis. 16:319–325.
  • Hargreaves A, Taylor WH. 1946. An X-ray examination of decomposition products of chrysotile (asbestos) and serpentine. Miner Mag. 27:204–216.
  • Harries PG. 1968. Asbestos hazards in naval dockyards. Ann Occup Hyg. 11:135–145.
  • Hatch D. 1970. Possible alternatives to asbestos as a friction material. Ann Occup Hyg. 13:25–29.
  • Hein MJ, Stayner LT, Lehman E, Dement JM. 2007. Follow-up study of chrysotile textile workers: cohort mortality and exposure–response. Occup Environ Med. 64:616–625.
  • Henderson DW, Rödelsperger K, Woitowitz H-J, Leigh J. 2004. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004. Pathology. 36:517–550.
  • Hessel PA, Teta MJ, Goodman M, Lau E. 2004. Mesothelioma among brake mechanics: an expanded analysis of a case-control study. Risk Anal. 24:547–552.
  • Hesterberg TW, Anderson R, Bernstein DM, Bunn WB, Chase GA, Jankousky AL, Marsh GM, McClellan RO. 2012. Product stewardship and science: safe manufacture and use of fiber glass. Regul Toxicol Pharmacol: RTP. 62:257–277.
  • Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Thevenaz P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol. 151:262–275.
  • Hesterberg TW, Hart GA, Chevalier J, Miiller WC, Hamilton RD, Bauer J, Thevenaz P. 1998. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol. 153:68–82.
  • Hodgson AA. 1979. Chemistry and physics of asbestos. In: Michaels L, Chissick SS, editors. Asbestos: properties, applications, and hazards. Hoboken, NJ: John Wiley & Sons; p. 67–114.
  • Hodgson JT, Darnton A. 2000. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 44:565–601.
  • Hodgson JT, Darnton A. 2010. Mesothelioma risk from chrysotile. Occup Environ Med. 67:432.
  • HSE. 2005. Asbestos: the analysts’ guide for sampling, analysis and clearance procedures. Sudbury, Suffolk: HSE Books.
  • HSE. 2009. Health and Safety in Motor Vehicle Repair and Associated Industries, HSG261 HSE Books, Sadbury, Suffolk.
  • Huncharek M, Muscat J, Capotorto JV. 1989. Pleural mesothelioma in a brake mechanic. Br J Ind Med. 46:69–71.
  • IARC. 1997. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 68. Silica, some silicates, coal dust and para-aramid fibrils.
  • IARC. 1977. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 14: Asbestos. Lyon: IARC.
  • IARC. 2012. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 100C: arsenic, metals, fibres and dusts. Lyon: IARC.
  • IARC. 2014. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 105: diesel and gasoline engine exhausts and some nitroarenes. Lyon: IARC.
  • Jarvholm B, Brisman J. 1988. Asbestos associated tumours in car mechanics. Br J Ind Med. 45:645–646.
  • Jiang L, Chew SH, Nakamura K, Ohara Y, Akatsuka S, Toyokuni S. 2016. Dual preventive benefits of iron elimination by desferal in asbestos-induced mesothelial carcinogenesis. Cancer Sci. 107:908–915.
  • Jones AD. 1993. Respirable industrial fibres: deposition, clearance and dissolution in animal models. Ann Occup Hyg. 37:211–226.
  • Kakooei H, Hormozy M, Marioryad H. 2011. Evaluation of asbestos exposure during brake repair and replacement. Ind Health. 49:374–380.
  • Kamp DW, Weitzman SA. 1999. The molecular basis of asbestos induced lung injury. Thorax. 54:638–652.
  • Kelsh MA, Craven VA, Teta MJ, Mowat FS, Goodman M. 2007. Mesothelioma in vehicle mechanics: is the risk different for Australians? Occup Med (Lond). 57:581–589.
  • Kerper LE, Lynch HN, Zu K, Tao G, Utell MJ, Goodman JE. 2015. Systematic review of pleural plaques and lung function. Inhal Toxicol. 27:15–44.
  • Kimizuka G, Wang NS, Hayashi Y. 1987. Physical and microchemical alterations of chrysotile and amosite asbestos in the hamster lung. J Toxicol Environ Health. 21:251–264.
  • Koshi K, Hayashi H, Sakabe H. 1969. Biological and mineralogical studies on serpentine minerals in heat treated state. Ind Health. 7:66–85.
  • Laden F, Stampfer MJ, Walker AM. 2004. Lung cancer and mesothelioma among male automobile mechanics: a review. Rev Environ Health. 19:39–61.
  • Langer AM, McCaughey WT. 1982. Mesothelioma in a brake repair worker. Lancet. 2:1101–1103.
  • Langer AM, Wolff MS, Rohl AN, Selikoff IJ. 1978. Variation of properties of chrysotile asbestos subjected to milling. J Toxicol Environ Health. 4:173–188.
  • Langer AM. 2003. Reduction of the biological potential of chrysotile asbestos arising from conditions of service on brake pads. Regul Toxicol Pharmacol. 38:71–77.
  • Lanphear BP, Buncher CR. 1992. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 34:718–721.
  • Lemen RA. 2004. Asbestos in brakes: exposure and risk of disease. Am J Ind Med. 45:229–237.
  • Lentz TJ, Rice CH, Succop PA, Lockey JE, Dement JM, LeMasters GK. 2003. Pulmonary deposition modeling with airborne fiber exposure data: a study of workers manufacturing refractory ceramic fibers. Appl Occup Environ Hyg. 18:278–288.
  • Lippmann M. 1990. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect. 88:311–317.
  • Loomis D, Dement J, Richardson D, Wolf S. 2010. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 67:580–584.
  • Lynch JR. 1968. Brake lining decomposition products. J Air Pollut Control Assoc. 18:824–826.
  • Madl AK, Gaffney SH, Balzer JL, Paustenbach DJ. 2009. Airborne asbestos concentrations associated with heavy equipment brake removal. Ann Occup Hyg. 53:839–857.
  • Madl AK, Scott LL, Murbach DM, Fehling KA, Finley BL, Paustenbach DJ. 2008. Exposure to chrysotile asbestos associated with unpacking and repacking boxes of automobile brake pads and shoes. Ann Occup Hyg. 52:463–479.
  • Ma-Hock L, Strauss V, Treumann S, Kuttler K, Wohlleben W, Hofmann T, Groters S, Wiench K, van Ravenzwaay B, Landsiedel R. 2013. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol. 10:23.
  • Maluf O, Angeloni M, Milan MT, Spinelli D, Bose Filho WW. 2006. Development of materials for automotive disc brakes. Minerva. 4:149–158.
  • Marcus K, Jarvholm BG, Larsson S. 1987. Asbestos-associated lung effects in car mechanics. Scand J Work Environ Health. 13:252–254.
  • Marinaccio A, Binazzi A, Cauzillo G, Cavone D, Zotti RD, Ferrante P, Gennaro V, Gorini G, Menegozzo M, Mensi C, et al. 2007. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer (Oxford, England: 1990). 43:2722–2728.
  • Maxim LD, Niebo R, Utell MJ. 2015. Are pleural plaques an appropriate endpoint for risk analyses? Inhal Toxicol. 27:321–334.
  • Mazurek J, Syamlal G, Wood J, Hendricks S, Weston A. 2017. Malignant mesothelioma mortality – United States, 1999–2015. MMWR Morb Mortal Wkly Rep. 66:214–218.
  • McDonald AD, Case BW, Churg A, Dufresne A, Gibbs GW, Sebastien P, McDonald JC. 1997. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg. 41:707–719.
  • McDonald AD, McDonald JC. 1980. Malignant mesothelioma in North America. Cancer. 46:1650–1656.
  • McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. 2005. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond). 55:79–87.
  • Meisenkothen C. 2017. Malignant mesothelioma in a motor vehicle mechanic: case report and review of the literature. New Solut. 26:524–542.
  • Mitchev K, Dumortier P, De VP. 2002. 'Black Spots' and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol. 26:1198–1206.
  • Morgan A, Holmes A, Gold C. 1971. Studies of the solubility of constituents of chrysotile asbestos in vivo using radioactive tracer techniques. Environ Res. 4:558–570.
  • Mossman B, Lippmann M, Hesterberg T, Kelsey K, Barchowsky A, Bonner J. 2011. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev. 14:76–121.
  • Mossman BT, Bignon J, Corn M, Seaton A, Gee JB. 1990. Asbestos: scientific developments and implications for public policy. Science (New York, NY). 247:294–301.
  • Mowat F, Bono M, Lee RJ, Tamburello S, Paustenbach D. 2005. Occupational exposure to airborne asbestos from phenolic molding material (Bakelite) during sanding, drilling, and related activities. J Occup Environ Hyg. 2:497–507.
  • Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. 2009. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci. 110:442–448.
  • Muller KM, Schmitz I, Konstantinidis K. 2002. Black spots of the parietal pleura: morphology and formal pathogenesis. Respiration. 69:261–267.
  • Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, et al. 2011. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol. 178:2587–2600.
  • Musk B, Gordon L, Alfonso H, Reid A, Olsen N, Mina R, Franklin P, Peters S, Brims F, Hui J. 2017. Risk factors for malignant mesothelioma in people with no known exposure to asbestos. Am J Ind Med. 60:432–436.
  • NIOSH. 1994. Asbestos by TEM: method 7402. Method no.
  • NOHSC. 2005. Guidance note on the membrane filter method for estimating airborne fibres. NOHSC: Canberra; p. 3003.
  • Oberdorster G, Graham U. 2018. Predicting EMP hazard: lessons from studies with inhaled fibrous and non-fibrous nano- and micro-particles. Toxicol Appl Pharmacol. 361:50–61.
  • Ohara Y, Chew SH, Shibata T, Okazaki Y, Yamashita K, Toyokuni S. 2018. Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats. Cancer Sci. 109:330–339.
  • Olsen JH, Jensen OM. 1987. Occupation and risk of cancer in Denmark. An analysis of 93,810 cancer cases, 1970–1979. Scand J Work Environ Health. 13 (Suppl.1):1–91.
  • Ostermeyer GP, Müller M. 2008. New insights into the tribology of brake systems. Proc Inst Mech Eng D: J Automob Eng. 222:1167–1200.
  • Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. 2005. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med. 172:1019–1025.
  • Panahi D, Kakooei H, Marioryad H, Mehrdad R, Golhosseini M. 2011. Evaluation of exposure to the airborne asbestos in an asbestos cement sheet manufacturing industry in Iran. Environ Monit Assess. 178:449–454.
  • Pascolo L, Gianoncelli A, Schneider G, Salomé M, Schneider M, Calligaro C, Kiskinova M, Melato M, Rizzardi C. 2013. The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning X-ray microscopy. Sci Rep. 3:1123.
  • Paustenbach DJ, Finley BL, Lu ET, Brorby GP, Sheehan PJ. 2004. Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 to present): a "state-of-the-art" review. J Toxicol Environ Health B Crit Rev. 7:25–80.
  • Paustenbach DJ, Richter RO, Finley BL, Sheehan PJ. 2003. An evaluation of the historical exposures of mechanics to asbestos in brake dust. Appl Occup Environ Hyg. 18:786–804.
  • Peeters PM, Eurlings IM, Perkins TN, Wouters EF, Schins RP, Borm PJ, Drommer W, Reynaert NL, Albrecht C. 2014. Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol. 11:58.
  • Pierce JS, McKinley MA, Paustenbach DJ, Finley BL. 2008. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma. Crit Rev Toxicol. 38:191–214.
  • Pierce JS, Ruestow PS, Finley BL. 2016. An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma. Crit Rev Toxicol. 46:561–586.
  • Plato N, Tornling G, Hogstedt C, Krantz S. 1995. An index of past asbestos exposure as applied to car and bus mechanics. Ann Occup Hyg. 39:441–454.
  • Poland CA, Byrne F, Cho W-S, Prina-Mello A, Murphy FA, Davies GL, Coey JMD, Gounko Y, Duffin R, Volkov Y, et al. 2012. Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology. 6:899–911.
  • Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, MacNee W, Donaldson K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotechnol. 3:423–428.
  • Poland CADR, Schinwald A, Donaldson K, Cherrie J. 2018. What makes a fibre hazardous to health? The asbestos origins of the fibre length threshold and its verification with nanotechnology. Occup Health. 15:21–26.
  • Povey A. 2008. Molecular assessment of exposure, effect, and effect modification. Epidemiology of work related diseases. London, UK: BMJ Publishing Group; p. 463–484.
  • Qi HS, Day AJ. 2007. Investigation of disc/pad interface temperatures in friction braking. Wear. 262:505–513.
  • Rittinghausen S, Hackbarth A, Creutzenberg O, Ernst H, Heinrich U, Leonhardt A, Schaudien D. 2014. The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats. Part Fibre Toxicol. 11:59.
  • Rodelsperger K, Jahn H, Bruckel B, Manke J, Paur R, Woitowitz HJ. 1986. Asbestos dust exposure during brake repair. Am J Ind Med. 10:63–72.
  • Rodelsperger K, Woitowitz HJ, Bruckel B, Arhelger R, Pohlabeln H, Jockel KH. 1999. Dose-response relationship between amphibole fiber lung burden and mesothelioma. Cancer Detect Prev. 23:183–193.
  • Roggli VL, George MH, Brody AR. 1987. Clearance and dimensional changes of crocidolite asbestos fibers isolated from lungs of rats following short-term exposure. Environ Res. 42:94–105.
  • Roggli VL, Vollmer RT, Butnor KJ, Sporn TA. 2002. Tremolite and mesothelioma. Ann Occup Hyg. 46:447–453.
  • Rohl AN, Langer AM, Klimentidis R, Wolff MS, Seilikoff IJ. 1977. Asbestos content of dust encountered in brake maintenance and repair. Proc R Soc Med. 70:32–37.
  • Rohl AN, Langer AM, Wolff MS, Weisman I. 1976. Asbestos exposure during brake lining maintenance and repair. Environ Res. 12:110–128.
  • Saber AT, Mortensen A, Szarek J, Koponen IK, Levin M, Jacobsen NR, Pozzebon ME, Mucelli SP, Rickerby DG, Kling K, et al. 2016. Epoxy composite dusts with and without carbon nanotubes cause similar pulmonary responses, but differences in liver histology in mice following pulmonary deposition. Part Fibre Toxicol. 13:37.
  • Sahu SC, Casciano D. 2009. Nanotoxicity: from in vivo and in vitro models to health risks. Chichester: John Wiley.
  • Salazar N, Cely-Garcia MF, Breysse PN, Ramos-Bonilla JP. 2015. Asbestos exposure among transmission mechanics in automotive repair shops. Ann Occup Hyg. 59:292–306.
  • Schinwald A, Chernova T, Donaldson K. 2012a. Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. Part Fibre Toxicol. 9:47.
  • Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, Glass JR, Dickerson JC, Schultz DA, Jeffree CE, et al. 2012b. The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci. 128:461–470.
  • Searl A, Buchanan D, Cullen R, Jones A, Miller B, Soutar C. 1999. Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg. 43:143–153.
  • Searl A. 1997. A comparative study of the clearance of respirable para-aramid, chrysotile and glass fibres from rat lungs. Ann Occup Hyg. 41:217–233.
  • Service RF. 1998. Nanotubes: the next asbestos? Science (New York, NY). 281:941.
  • Spirtas R, Keehn R, Wright W, Stark A, Beebe G, Dickson E. 1985. Mesothelioma risk related to occupational or other asbestos exposure – preliminary results from a case-control study. Am J Epidemiol. 122:518–518.
  • Stanton M, Layard M, Tegeris A, Miller E, May M, Morgan E. 1981. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. JNCI. 67:965–975.
  • Stanton MF, Wrench C. 1972. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 48:797–821.
  • Stayner LT, Dankovic DA, Lemen RA. 1996. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 86:179–186.
  • Suzuki Y, Yuen SR, Ashley R. 2005. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 208:201–210.
  • Takata A, Yamauchi H, Toya T, Aminaka M, Shinohara Y, Kohyama N, Yoshida K. 2009. Forsterite exposure causes less oxidative DNA damage and lung injury than chrysotile exposure in rats. Inhal Toxicol. 21:739–746.
  • Teschke K, Morgan MS, Checkoway H, Franklin G, Spinelli JJ, van Belle G, Weiss NS. 1997. Mesothelioma surveillance to locate sources of exposure to asbestos. Can J Public Health. 88:163–168.
  • Teschke K. 2016. Thinking about occupation-response and exposure–response relationships: vehicle mechanics, chrysotile, and mesothelioma. Ann Occup Hyg. 60:528–530.
  • Teta MJ, Lewinsohn HC, Meigs JW, Vidone RA, Mowad LZ, Flannery JT. 1983. Mesothelioma in Connecticut, 1955–1977. Occupational and geographic associations. J Occup Med. 25:749–756.
  • The Royal Society, Royal Academy of Engineering. 2004. Nanoscience and nanotechnologies: opportunities and uncertainties. London: The Royal Society.
  • Trittschack R, Grobéty B. 2013. The dehydroxylation of chrysotile: a combined in situ micro-Raman and micro-FTIR study. Am Mineral. 98:1133–1145.
  • Turci F, Tomatis M, Lesci IG, Roveri N, Fubini B. 2011. The iron-related molecular toxicity mechanism of synthetic asbestos nanofibres: a model study for high-aspect-ratio nanoparticles. Chem Eur J. 17:350–358.
  • Turi JL, Yang F, Garrick MD, Piantadosi CA, Ghio AJ. 2004. The iron cycle and oxidative stress in the lung. Free Radic Biol Med. 36:850–857.
  • Vainio H, Boffetta P. 1994. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health. 20:235–242.
  • Valavanidis A, Vlachogianni T, Fiotakis K, Loridas S. 2013. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. IJERPH. 10:3886–3907.
  • Valentine R, Chang MJ, Hart RW, Finch GL, Fisher GL. 1983. Thermal modification of chrysotile asbestos: evidence for decreased cytotoxicity. Environ Health Perspect. 51:357–368.
  • Virta RL. 2002. Asbestos geology, mineralogy, mining, and uses. Vol. Version 1.0. Reston, VA: U.S. Dept. of the Interior, U.S. Geological Survey (US Geological Survey Open-File Report).
  • Virta RL. 2006. Worldwide asbestos supply and consumption trends from 1900 through 2003. Vol. 1298. Reston (VA): U.S. Geological Survey. (US Geological Survey Circular; iv, 80 p).
  • Wagner JC, Sleggs CA, Marchand P. 1960. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 17:260–271.
  • Wang J, Schlagenhauf L, Setyan A. 2017. Transformation of the released asbestos, carbon fibers and carbon nanotubes from composite materials and the changes of their potential health impacts. J Nanobiotechnol. 15:15.
  • Wang NS. 1975. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am Rev Respir Dis. 111:12–20.
  • Wang NS. 1985. Anatomy and physiology of the pleural space. Clin Chest Med. 6:3–16.
  • Weir FW, Meraz LB. 2001. Morphological characteristics of asbestos fibers released during grinding and drilling of friction products. Appl Occup Environ Hyg. 16:1147–1149.
  • Welch LS, Acherman YIZ, Haile E, Sokas RK, Sugarbaker PH. 2005. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health. 11:254–258.
  • Welch LS. 2007. Asbestos exposure causes mesothelioma, but not this asbestos exposure: an amicus brief to the Michigan Supreme Court. Int J Occup Environ Health. 13:318–327.
  • WHO. 1997. Determination of airborne fibre number concentrations: a recommended method, by phase-contrast optical microscopy (membrane filter method).Geneva: World Health Organization.http://www.who.int/iris/handle/10665/41904
  • Wohlleben W, Brill S, Meier MW, Mertler M, Cox G, Hirth S, von Vacano B, Strauss V, Treumann S, Wiench K. 2011. On the lifecycle of nanocomposites: comparing released fragments and their in-vivo hazards from three release mechanisms and four nanocomposites. Small. 7(16):2384–2395.
  • Woitowitz HJ, Rodelsperger K. 1994. Mesothelioma among car mechanics? Ann Occup Hyg. 38:635–638.
  • Wong O. 2001. Malignant mesothelioma and asbestos exposure among auto mechanics: appraisal of scientific evidence. Regul Toxicol Pharmacol. 34:170–177.
  • Wong O. 2006. The interpretation of occupational epidemiologic data in regulation and litigation: studies of auto mechanics and petroleum workers. Regul Toxicol Pharmacol: RTP. 44:191–197.
  • Woźniak H, Wiecek E, Bielichowska-Cybula G. 1991. The fibrogenic activity and neurotoxicity of heat-treated chrysotile. Pol J Occup Med Environ Health. 4:21–31.
  • Yoshikawa N, Kashimura K, Hashiguchi M, Sato M, Horikoshi S, Mitani T, Shinohara N. 2015. Detoxification mechanism of asbestos materials by microwave treatment. J Hazard Mater. 284:201–206.
  • Zaremba T, Krząkała A, Piotrowski J, Garczorz D. 2010. Study on the thermal decomposition of chrysotile asbestos. J Therm Anal Calorim. 101:479–485.
  • Zhang H, Ji Z, Xia T, Meng H, Low-Kam C, Liu R, Pokhrel S, Lin S, Wang X, Liao Y-P, et al. 2012. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano. 6:4349–4368.